Eli Lilly Corp. diskutieren
Eli Lilly Corp.
WKN: 858560 / Symbol: LLY / Name: Eli Lilly / Aktie / Pharmazeutika / Large Cap /
656,90 €
-2,96 %
Eli Lilly and Company (NYSE: LLY) had its price target lowered by analysts at Guggenheim from $973.00 to $928.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $975.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) was downgraded by analysts at HSBC Holdings plc from a "buy" rating to a "reduce" rating. They now have a $700.00 price target on the stock, down previously from $1,150.00.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $936.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its "overweight" rating re-affirmed by analysts at Morgan Stanley.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Guggenheim from $936.00 to $942.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Neueste Beiträge
UBS_Group_AG in UnitedHealth Group Inc. diskutieren